Brought to you by:
Powered by wagescape.com
Labor Market Pulse
Longview, TX Metro Edition
Focus: LIFE SCI
5.3%
Longview MSA unemployment rate
Up from 4.3% in March 2026
21.6%
Texas life sciences employer growth
Since 2019, outpacing talent pipeline growth
123,900
Longview nonfarm payrolls
Aug 2026, +300 monthly, +0.6% annual
$123,068
Texas pharma subsector wage avg
56.2% employer growth since 2019
This Month's Takeaways
Longview's unemployment rate rose from 4.3% to 5.3% between March and June 2026, but this slack concentrates in lower-skill occupations, not the credentialed scientific and regulatory roles life sciences employers compete for statewide.
Metro median advertised pay for Research Scientist reached $125,310, up significantly year-over-year but still $6,000 below the national median of $131,354 — a gap that may widen further if Houston's biomanufacturing buildout pulls senior scientific talent out of smaller Texas metros.
Advertised CRA pay rose significantly both locally ($81,374) and nationally ($90,956), consistent with sustained clinical trial activity competing for a limited credentialed pool — a trend that should inform whether CRO partnerships or in-house clinical ops hiring better absorbs near-term cost increases.
Eli Lilly's $6.5B and Bristol Myers' $2.3B Generation Park facilities create over 600 new jobs each, raising the realistic recruiting radius for quality and manufacturing specialists that Longview-based employers may have assumed were locally available.
Local Labor Conditions
Longview MSA unemployment climbed to 5.3% in June 2026 from 4.3% in March, even as nonfarm payrolls edged up to 123,900 by August, pointing to a labor market adding jobs slowly while labor supply loosens. Manufacturing and healthcare remain the metro's largest employment bases, but neither shows the acceleration seen in Houston's biomanufacturing corridor or statewide construction and professional services growth, leaving Longview-based life sciences employers reliant on a shallow local specialist pool.
Leadership & Talent Implications
Rising metro unemployment alongside flat-to-soft payroll growth suggests Longview life sciences employers face less wage pressure on general lab and support roles than peer Texas metros, but credentialed scientific, quality, and regulatory talent remains scarce regardless of local slack — these roles draw from a statewide or national pool, not the Gregg County labor force. Build-vs-outsource calculus should account for the fact that Houston's Lilly and Bristol Myers manufacturing expansions are pulling experienced operators and quality specialists toward Generation Park, potentially widening the recruiting radius and cost needed to retain comparable talent in Longview. Consider reviewing whether current compensation for regulatory and senior research roles reflects statewide competition rather than local market softness.
Advertised Pay Indicators
| Role | P25 | Median | P75 | Local Trend | National | Nat. Trend |
|---|---|---|---|---|---|---|
| Research Scientist | $84,986 | $125,310 | $136,499 | ↑ Significant increase | $131,354 | ↑ Significant increase |
| Clinical Research Associate | $58,220 | $81,374 | $98,325 | ↑ Significant increase | $90,956 | ↑ Significant increase |
| Lab Technician | $37,740 | $45,314 | $49,226 | → Stable | $47,402 | ↓ Moderate decline |
| Regulatory Affairs Specialist | — | — | — | — No data | $104,000 | → Stable |
| Clinical Data Manager | — | — | — | — No data | $123,031 | ↓ Moderate decline |
| Biostatistician | — | — | — | — No data | $133,322 | ↑ Moderate increase |
| Validation Engineer | — | — | — | — No data | $108,377 | ↑ Moderate increase |
Some roles reflect state-level data where local metro sample size was insufficient.
Looking Ahead · Next 30–60 Days
Expected
BLS will release September 2026 Longview MSA unemployment and payroll data in mid-to-late October — watch whether the June-to-August softening trend continues, which would support more aggressive local hiring for non-credentialed roles.
Emerging pressure point
Houston's biomanufacturing expansion (Lilly, Bristol Myers at Generation Park) is scaling through 2026-2027; track whether Longview-based quality and manufacturing specialists are recruited away, which would tighten an already thin regional bench.
Worth watching
National biopharma layoffs (BioMarin, Bristol Myers Squibb) are concentrated in consolidation functions, not execution roles — monitor whether any displaced regulatory or CMC talent enters the Texas candidate pool via relocation.
Early indicator
San Jacinto College's NIBRT-licensed biotech training center, now a year into operation, may begin producing technician-level graduates — watch whether this eases Lab Technician hiring pressure in East Texas before it affects higher-credential roles.
WageScape Member Benefit
Your Pulse covers one metro and one function or industry. Add coverage if you want to see the latest intelligence for other markets, industries, or functions.
Pulse Plus
3 metro reports
$149/year
Pulse Pro
10 metro reports
$349/year
Enterprise
10+ markets
Contact us
WageTrak · 15% Member Discount
On-demand advertised pay data across thousands of job titles, all metro areas, full percentile coverage, and monthly updates. Use code WAGESCAPE15 at wagetrak.com.
Forwarded This Briefing?
Receive your own personalized monthly briefing, filtered to your local market. Scan to enroll below.